Logo
Home
About
Articles
FAQ
Sign In
Search
Join the mailing list
Logo
Search
Home
About
Articles
FAQ
Sign In
Join the mailing list
Oliver Buchannon
Christina Farr

Christina is an advisor to early- and late-stage healthcare companies on go-to-market strategy, storytelling, and fundraising, and shares her insights via Second Opinion. Learn more at www.chrissyfarr.com

ICHRA is gaining momentum - and if so, what does it mean for health-tech?

I teamed up with two health policy experts to explore the bull and bear case.

Christina Farr, +2
Nov 26, 2024
ICHRA is gaining momentum - and if so, what does it mean for health-tech?

Interested in sponsoring Second Opinion?
Reach out!

I consent to receive newsletters via email. Terms of use and Privacy policy.